市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | PTC Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
-0.3
| 分析师共识 | -1.5 |
| 内部交易活动 | -3.5 |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | -0.30 |
|
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 2.40% |
| 机构持股比例 | 101.06% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 93.00 (Wells Fargo, 19.46%) | 购买 |
| 中 | 75.00 (-3.66%) | |
| 低 | 50.00 (Goldman Sachs, -35.77%) | 卖出 |
| 平均值 | 73.86 (-5.13%) | |
| 总计 | 2 购买, 4 保留, 1 卖出 | |
| 平均价格@调整类型 | 72.34 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| RBC Capital | 01 Dec 2025 | 91.00 (16.89%) | 保留 | 79.20 |
| 05 Nov 2025 | 82.00 (5.33%) | 购买 | 71.77 | |
| Barclays | 06 Nov 2025 | 68.00 (-12.65%) | 保留 | 72.59 |
| Citigroup | 05 Nov 2025 | 75.00 (-3.66%) | 保留 | 71.77 |
| Goldman Sachs | 05 Nov 2025 | 50.00 (-35.77%) | 卖出 | 71.77 |
| TD Cowen | 05 Nov 2025 | 63.00 (-19.08%) | 保留 | 71.77 |
| Wells Fargo | 05 Nov 2025 | 93.00 (19.46%) | 购买 | 71.77 |
| Jefferies | 28 Oct 2025 | 77.00 (-1.09%) | 购买 | 67.49 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| ALMSTEAD NEIL GREGORY | - | 81.38 | -107,500 | -8,804,702 |
| JACOBSON ALLAN STEVEN | - | 81.38 | -26,000 | -2,119,597 |
| REEVE EMMA | - | 78.47 | -10,000 | -784,700 |
| 累积净数量 | -143,500 | |||
| 累积净值 ($) | -11,708,999 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 80.80 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| JACOBSON ALLAN STEVEN | 董事 | 25 Nov 2025 | 自动卖出 (-) | 14,199 | 82.93 | 1,177,523 |
| JACOBSON ALLAN STEVEN | 董事 | 25 Nov 2025 | 执行期权 | 14,199 | - | - |
| ALMSTEAD NEIL GREGORY | 职员 | 25 Nov 2025 | 自动卖出 (-) | 71,928 | 82.93 | 5,964,989 |
| ALMSTEAD NEIL GREGORY | 职员 | 25 Nov 2025 | 执行期权 | 71,928 | - | - |
| JACOBSON ALLAN STEVEN | 董事 | 24 Nov 2025 | 自动卖出 (-) | 11,801 | 79.83 | 942,074 |
| JACOBSON ALLAN STEVEN | 董事 | 24 Nov 2025 | 执行期权 | 11,801 | - | - |
| ALMSTEAD NEIL GREGORY | 职员 | 24 Nov 2025 | 自动卖出 (-) | 35,572 | 79.83 | 2,839,713 |
| ALMSTEAD NEIL GREGORY | 职员 | 24 Nov 2025 | 执行期权 | 35,572 | - | - |
| REEVE EMMA | 董事 | 21 Nov 2025 | 自动卖出 (-) | 10,000 | 78.47 | 784,700 |
| REEVE EMMA | 董事 | 21 Nov 2025 | 执行期权 | 10,000 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合